Modulated EMS for the New Year Reset: A 90-Day Face Refresh Protocol
About the Authors
Bertica M. Rubio, M.D.
Medizinischer Direktor, Anti-Aging-Regenerationsmedizinische Klinik | Facharzt | Dartmouth Medical School
Dr. Bertica M. Rubio ist eine zertifizierte Ärztin und medizinische Leiterin der Anti-Aging-Regenerationsklinik in Redlands, Kalifornien. Sie erwarb ihren Bachelor of Science an der Loyola Marymount University und ihren Doktortitel in Medizin an der Dartmouth Medical School (Geisel School of Medicine). Ihre Facharztausbildung in Pädiatrie absolvierte sie am UC Irvine Medical Center.
Mit jahrzehntelanger klinischer Erfahrung spezialisiert sich Dr. Rubio auf Altersmanagement, regenerative Medizin, Wundheilung und Wachstumsfaktor-Therapien. Ihre Praxis verbindet evidenzbasierte medizinische Wissenschaft mit fortschrittlichen ästhetischen und regenerativen Behandlungen, um Patienten zu optimaler Gesundheit und jugendlicher Vitalität zu verhelfen.
Dr. Rubio ist leidenschaftlich daran interessiert, Patienten über die Wissenschaft hinter Hautpflege, Gesichtsverjüngung und nicht-invasiven Technologien wie EMS (Elektrische Muskelstimulation) zur Gesichtstonung aufzuklären. Ihre Artikel für PureLift LAB verbinden fundiertes medizinisches Wissen mit praktischen Anleitungen für echte, nachhaltige Ergebnisse.
Andrew Conrad Barile, Physiotherapeut, Doktor der Physiotherapie
Doktor der Physiotherapie (DPT), Lizenzierter Physiotherapeut (PT)
Dr. Andrew Conrad Barile ist Doktor der Physiotherapie sowie CEO und Gründer von Xtreem Pulse LLC. Er erwarb seinen Doktortitel in Physiotherapie am Daemen College und bringt über zwei Jahrzehnte klinische und unternehmerische Erfahrung in der pädiatrischen Physiotherapie, Craniosacraltherapie und medizinischen Geräteinnovation mit. Sein tiefes Verständnis der menschlichen Anatomie, Muskelphysiologie und therapeutischen Technologie bietet einen wissenschaftlich fundierten Ansatz für Gesichtsverjüngung und Anti-Aging-Lösungen.
Daniel Grinberg, MD, FACS
Facharzt für Hals-Nasen-Ohren-Heilkunde und Kopf-Hals-Chirurgie | Fellow des American College of Surgeons | Assistenz-Professor für Klinische Medizin, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS, ist ein von der Ärztekammer zertifizierter Hals-Nasen-Ohren-Arzt und Kopf-Hals-Chirurg bei ENT and Allergy Associates in West Nyack, NY. Er erwarb seinen medizinischen Abschluss an der Columbia University College of Physicians and Surgeons, absolvierte seine Facharztausbildung in Hals-Nasen-Ohren-Heilkunde am New York University Medical Center und ist Assistenzprofessor an der Mount Sinai School of Medicine. Er ist Fellow sowohl des American College of Surgeons als auch der American Academy of Otolaryngology.
Dr. Grinbergs Perspektive als Kopf-Hals-Chirurg bietet den Lesern von PureLift LAB eine erweiterte klinische Sichtweise — er verbindet die EMS-Anwendung zu Hause mit der zugrunde liegenden medizinischen Anatomie mit derselben wissenschaftlichen Genauigkeit, die wir auf jede Gerätespezifikation anwenden.
Prof. Dr. med. Ivo Buschmann
Lehrstuhl für Angiologie, Medizinische Hochschule Brandenburg | Klinikdirektor, Universitätsklinik für Angiologie, Brandenburgisches Klinikum | Ehemaliger Oberarzt, Charité Universitätsmedizin Berlin
Prof. Dr. med. Ivo Buschmann ist Lehrstuhlinhaber für Angiologie an der Medizinischen Hochschule Brandenburg Theodor Fontane (MHB) und Klinikdirektor der Universitätsklinik für Angiologie am Brandenburgischen Universitätsklinikum. Er absolvierte seine medizinische Ausbildung an der Universität Hamburg, war Max-Planck-Gesellschaft-Stipendiat am Max-Planck-Institut für Herz- und Lungenforschung und hatte leitende Oberarztpositionen an der Charité Universitätsmedizin Berlin Campus Virchow inne, bevor er 2016 zum Lehrstuhlinhaber an der MHB berufen wurde.
Prof. Buschmann ist einer der führenden europäischen Experten für Arteriogenese – das durch Fluss angetriebene Wachstum und die Umgestaltung von Blutgefäßen – mit mehr als 150 begutachteten Veröffentlichungen und mehreren US- und EU-Patenten für Geräte, die das Wachstum von Kollateralgefäßen durch kontrollierte Scherkräfte-Therapie stimulieren. Seine Forschung verbindet mechanische und elektrische Stimulation mit vaskulärer Anpassung, Mikrozirkulation und Gewebeperfusion.
Die Beiträge von Prof. Buschmann bieten den Lesern von PureLift LAB eine gefäßbiologische Perspektive, die unsere bestehenden Autoren aus den Bereichen Klinik, Physiotherapie und chirurgische Anatomie ergänzt – und erklären, wie EMS-Stimulation nicht nur die Gesichtsmuskeln, sondern auch die Mikrozirkulation, die sie versorgt, aktiviert und warum eine intelligente Anwendung auf der Ebene des Blutflusses ebenso wichtig ist wie die Muskelkontraktion.
Teilen
A new year can be a useful prompt to make a facial-device routine more consistent, but a calendar cannot guarantee a biological result. A 90-day PureLift reset is best understood as a structured period for learning technique, building a repeatable habit, and comparing like-for-like photographs. It is not a promise that every face will change by the same amount or on the same date. Age, anatomy, starting muscle condition, skincare, treatment history, and adherence all influence what a person may see.
The strongest version of this plan is therefore deliberately measured. It gives the routine enough time to become familiar, keeps other variables as stable as practical, and uses three monthly reviews to decide what is worth continuing. The goal is a fair test of a Next-Gen EMS routine, not a dramatic countdown to a predetermined transformation.
What a 90-day window can actually do
Ninety days is long enough to move beyond first impressions. Sensation, conductive-medium coverage, probe pressure, movement speed, and intensity selection all take practice. A longer window also reduces the temptation to judge progress from one unusually puffy morning, one flattering photograph, or one session that felt different from the last. Those short-term observations can be real to the user, but they are not a reliable measure of cumulative change.
The window is also compatible with the duration of published facial-stimulation studies without turning their endpoints into a guarantee. Research protocols have assessed outcomes after several weeks, not after a single use. Their schedules, devices, participants, and measurements are not interchangeable with a PureLift home routine. The practical value of 90 days is consistency and documentation, not a claim that the research predicts an individual result.
Establish a credible starting point
Before the first session, take neutral photographs from the front, both three-quarter views, and both profiles. Use the same room, camera, lens, distance, expression, head position, and time of day whenever possible. Avoid comparing a smiling image with a neutral one, or a close wide-angle phone image with a later portrait-mode image. Small photographic differences can create an apparent contour change that has nothing to do with the routine.
Record the device model, starting intensity, session frequency, conductive medium, and any relevant changes in skincare or professional treatments. This is not about turning skincare into a laboratory. It simply prevents a later conclusion from being based on incomplete memory. If several variables change at once, any difference in appearance cannot responsibly be assigned to PureLift alone.
Days 1 to 30, learn the routine
The first month should prioritize repeatability over intensity chasing. Follow the current product directions, use sufficient compatible conductive medium, keep the probe in full contact, and move through the intended facial and neck areas with controlled passes. Increase intensity only within comfort and only as directed. A stronger setting is not automatically a better setting, and discomfort is not evidence of effectiveness.
PureLift sessions are designed to last 10 minutes. Choose a weekly cadence you can sustain under the device instructions and keep it stable enough to evaluate. If the skin becomes unusually reactive, stop and reassess technique, medium, pressure, and skincare compatibility rather than forcing the schedule. At the end of the month, review comfort and consistency first. Photographs may or may not show a difference at this stage, and either result is information rather than a verdict.
Days 31 to 60, improve control without rewriting the plan
During the second month, refine the variables that affect delivery. Check whether the serum remains evenly distributed, whether the probe lifts away around curved areas, and whether movement has become rushed. The aim is visible, comfortable engagement at appropriate higher output settings where the device directions call for muscle work. Levels 1 and 2 are low-power modes and should not be described as adding muscle activation.
Avoid responding to impatience by adding multiple extra sessions, changing skincare actives, and increasing intensity at the same time. That makes both tolerance and outcome harder to interpret. Keep a short note after each session about comfort and technique. At day 60, repeat the baseline photographs under matched conditions, then look for patterns across the complete set rather than searching for a single favorable angle.
Days 61 to 90, make the assessment useful
The final month is not a peak-performance phase that requires pushing harder. It is a continuation phase. Maintain the approach that has been comfortable and repeatable. If professional treatments, illness, travel, or skin irritation interrupt the schedule, record the interruption without trying to compensate with aggressive use. A realistic log is more useful than a nominally perfect plan.
At day 90, repeat the photographs and review the entire period. Look at resting contour and overall appearance, not isolated shadows or expression lines. Ask whether the routine is practical, whether use has been comfortable, and whether any observed appearance change matters to you. A subtle result that comes from a sustainable routine may be more valuable than a dramatic photograph produced by different lighting or posture.
How the PureLift technology fits the plan
PureLift defines its category as Next-Gen EMS. Its PDM architecture combines Dynamic Modulation™, which cycles through 361 frequencies across the 1,370 to 1,730 Hz band, with Triple-Wave™, which layers three simultaneous frequency components designed for different tissue depths. Evidence from electrical-stimulation research supports modulation as a general approach to reducing accommodation compared with constant delivery. It does not independently prove that PureLift's specific implementation will produce a particular cosmetic outcome for every user.
The five-model range uses the same PDM foundation, while output and features differ by model. Pro Plus and Glow can reach up to 9 mA. The maximum outputs of Face, Pro, and Pro Edition have not been supplied and should not be inferred. All five models are FDA cleared as Class II devices and are made in Japan in ISO 9001 and ISO 13485 facilities. Those facts establish product and manufacturing context, but they do not convert a 90-day routine into a predefined outcome.
What the research does and does not establish
Kavanagh and colleagues reported a 12-week facial electrical-stimulation protocol and measured changes under that specific study design. It is relevant to the broader facial-stimulation evidence base, but its schedule and device should not be treated as a PureLift trial. It also does not establish that a particular user has a visible change at week 12.
Omatsu and colleagues reported week-eight cosmetic endpoints in 2024, but the tested intervention was multimodal. It was a prospective split-face controlled study, not a randomized trial. It combined 40 to 190 kHz facial neuromuscular electrical stimulation with iontophoresis, LED, and cooling. The study therefore cannot isolate an fNMES-specific effect, cannot be treated as PureLift evidence, and does not demonstrate a one-session result. See PMID 38992992. A 2026 correction, PMID 41834264, disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments. The correction stated that the results and conclusions were unchanged.
Build the supporting routine around stability
Keep the surrounding skincare simple enough that the skin remains comfortable. Daily sun protection, a gentle cleanser, and barrier-supportive moisturization can make a device routine easier to maintain. These steps support general skin care; they are not mechanisms by which PDM is proven to accelerate circulation, lymphatic drainage, oxygen delivery, healing, or recovery. PureLift should be described according to its electrical-stimulation function and cosmetic appearance role.
For a wider discussion of how movement and facial appearance can relate without overclaiming cause, read From Puffy to Sculpted. For a closer look at the early habit-building period, see Your First 30 Days With PureLift.
The right conclusion at day 90
A useful 90-day reset ends with a decision, not a marketing verdict. If photographs, comfort, and personal experience support continuing, choose a maintenance cadence that follows the current device directions and fits real life. If the result is unclear, check technique and expectations before assuming that more intensity is the answer. If the routine is uncomfortable or a health condition raises questions, stop and seek appropriate professional advice.
The value of the framework is that it replaces guesswork with consistency. It respects the difference between published research and a home device, and it leaves room for individual response. Power matters. Delivery matters more. Neither replaces careful use, honest documentation, or realistic expectations.